Min Shen
Nanjing Agricultural University(CN)National Institutes of Health(US)Shandong University of Traditional Chinese Medicine(CN)Tunghai University(TW)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Chengdu Medical College(CN)Peking Union Medical College Hospital(CN)National Clinical Research Center for Digestive Diseases(CN)Bioscience Research(US)Shanghai Sunshine Rehabilitation Center(CN)National Center for Advancing Translational Sciences(US)Yunnan Open University(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cancer, Hypoxia, and Metabolism, SARS-CoV-2 and COVID-19 Research, Biochemical and Molecular Research, COVID-19 Clinical Research Studies
Most-Cited Works
- → Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses(2011)1,171 cited
- → Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19(2020)956 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited
- → Rational selection of training and test sets for the development of validated QSAR models(2003)702 cited
- → Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors(2016)598 cited
- → A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate(2016)578 cited